JUL 11, 2017 3:47 PM PDT

First Vaccine to Show Protection Against Gonorrhea

WRITTEN BY: Xuan Pham

The World Health Organization recently reported on the alarming rise of “super gonorrhea” that can outmaneuver our current arsenal of antibiotics. In response, researchers are working harder than ever on a gonorrhea vaccine, and a recent study demonstrated some promise for such a vaccine in the future.

Image credit: Pixabay.com

The CDC reports that gonorrhea is the “second most commonly reported notifiable disease in the United States,” affecting more than 700,000 Americans every year. The disease is caused by the bacterium Neisseria gonorrhoeae, which spread through unprotected sex with an infected individual. Once in the host, the pathogen can cause to pelvic inflammatory disease, which, for women, can lead to infertility, ectopic pregnancy, and chronic pelvic pain.

"The bacteria that cause gonorrhea are particularly smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them," explained Dr. Teodora Wi, Medical Officer, Human Reproduction, at WHO. "These cases may just be the tip of the iceberg, since systems to diagnose and report untreatable infections are lacking in lower-income countries where gonorrhea is actually more common.”

In response, researchers from New Zealand recently published their results on a gonorrhea vaccine that, for the first time, showed protection against the infection. In about 15,000 young people, the vaccine cut infections by about a third.

Surprisingly, this vaccine for gonorrhea did not start out as a vaccine specific to the Neisseria gonorrhoeae pathogen. Rather, researchers noticed that a vaccine for meningitis B seemed to offer cross protection against gonorrhea too. Upon closer investigation, the scientists noted the bacteria responsible for the two diseases are close relatives that share the same genus (Neisseria meningitides and Neisseria gonorrhoeae). About a third of the teens that were vaccinated against meningitis B between 2004 and 2006 in New Zealand also had protection against gonorrhea that lasted for about two years.

"This is the first time a vaccine has shown any protection against gonorrhea,” said Dr. Helen Petousis-Harris, one of the researchers. "At the moment, the mechanism behind this immune response is unknown, but our findings could inform future vaccine development." She noted that exposure to the pathogen does not naturally induce immunity or resistance; thus, immunity has to come from an external source.

“To control gonorrhoea, we need new tools and systems for better prevention, treatment, earlier diagnosis, and more complete tracking and reporting of new infections, antibiotic use, resistance and treatment failures,” said Dr. Marc Sprenger, Director of Antimicrobial Resistance at WHO. “Specifically, we need new antibiotics, as well as rapid, accurate, point-of-care diagnostic tests – ideally, ones that can predict which antibiotics will work on that particular infection – and longer term, a vaccine to prevent gonorrhea.”

Additional sources: BBC, WHO

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 18, 2019
Health & Medicine
SEP 18, 2019
Honey As An Antibacterial Against Methicillin-Resistant Staphylococcus Aureus
Honey has been used for its medicinal properties for thousands of years to treat wound infections, gastrointestinal...
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the ot...
NOV 05, 2019
Cannabis Sciences
NOV 05, 2019
Single Exposure to CBD & THC Disrupts Embryonic Development
It only takes one incidence of cannabinoid exposure during the first month of pregnancy to yield detrimental effects on a developing embryo. New research r
DEC 23, 2019
Clinical & Molecular DX
DEC 23, 2019
Long awaited at-home test gives hemophiliacs peace of mind
Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. Blood clotting is a natural protecti
MAR 23, 2020
Microbiology
MAR 23, 2020
The Loss of a Sense of Smell May be a Major Symptom of COVID-19
The loss of the sense of smell may be a symptom of a COVID-19 infection in people with no other symptoms.
APR 01, 2020
Cardiology
APR 01, 2020
Avoiding Caries in Children
Thankfully, children are free of many of the chronic diseases that plague older populations. That said, one of the most common chronic diseases children do
Loading Comments...